Publications
- Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data2021 | Second Faculty of Medicine
- Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study2020 | Second Faculty of Medicine
- Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study2019 | Second Faculty of Medicine
- Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial2018 | Publication without faculty affiliation
- The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial2015 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/012014 | Publication without faculty affiliation
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group2013 | Publication without faculty affiliation
- History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic2011 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic2010 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Physical Education and Sport
- Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study2024 | Second Faculty of Medicine
Loading network view...